Skip to main content
Top
Published in: Diabetologia 12/2005

01-12-2005 | Article

Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes

Authors: A. C. Holloway, G. E. Lim, J. J. Petrik, W. G. Foster, K. M. Morrison, H. C. Gerstein

Published in: Diabetologia | Issue 12/2005

Login to get access

Abstract

Aims/hypothesis

Epidemiological studies report an increased risk of obesity and type 2 diabetes in children born to women who smoked during pregnancy. This study examines the effect of fetal and neonatal exposure to nicotine, the major addictive component of cigarettes, on postnatal growth, adiposity and glucose homeostasis.

Methods

Female Wistar rats were given either saline (vehicle) or nicotine (1 mg kg−1 day−1) during pregnancy and lactation. Serum and pancreas tissue were collected from the infant rats at birth. Postnatal growth was assessed weekly until the rats reached 26 weeks of age and glucose homeostasis was examined by OGTTs performed at 7 and 26 weeks of age.

Results

Exposure to nicotine resulted in increased postnatal growth and adiposity. Nicotine exposure also resulted in dysglycaemia at 7 and 26 weeks of age. Serum insulin concentrations were decreased in the pups exposed to nicotine at birth. This was associated with increased beta cell apoptosis (pups of saline-treated mothers 8.8±1.21% apoptotic beta cells; pups of nicotine-treated mothers 27.8±3.1% apoptotic beta cells).

Conclusions/interpretation

Fetal and neonatal exposure to nicotine results in metabolic changes in the offspring that are consistent with obesity and type 2 diabetes. We propose that these metabolic changes may be a consequence of the initial insult to the beta cell during fetal life and that this animal model has many characteristics of diabetes in humans.
Literature
1.
go back to reference Bergmann KE, Bergmann RL, von Kries R et al (2003) Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast feeding. Int J Obesity 27:162–172CrossRef Bergmann KE, Bergmann RL, von Kries R et al (2003) Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast feeding. Int J Obesity 27:162–172CrossRef
2.
go back to reference Blake KV, Currin LC, Evans SF et al (2000) Maternal cigarette smoking during pregnancy, low birth weight and subsequent blood pressure in early childhood. Early Hum Dev 57:137–147CrossRefPubMed Blake KV, Currin LC, Evans SF et al (2000) Maternal cigarette smoking during pregnancy, low birth weight and subsequent blood pressure in early childhood. Early Hum Dev 57:137–147CrossRefPubMed
3.
go back to reference Montgomery SM, Ekbom A (2002) Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ 324:26–27CrossRefPubMed Montgomery SM, Ekbom A (2002) Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ 324:26–27CrossRefPubMed
4.
go back to reference Morley R, Leeson Payne C, Lister G, Lucas A (1995) Maternal smoking and blood pressure in 7.5 to 8-year old offspring. Arch Dis Child 72:120–124PubMedCrossRef Morley R, Leeson Payne C, Lister G, Lucas A (1995) Maternal smoking and blood pressure in 7.5 to 8-year old offspring. Arch Dis Child 72:120–124PubMedCrossRef
5.
go back to reference Toschke AM, Koletzko B, Slikker W Jr, Hermann M, von Kries R (2002) Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr 161:445–448CrossRefPubMed Toschke AM, Koletzko B, Slikker W Jr, Hermann M, von Kries R (2002) Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr 161:445–448CrossRefPubMed
6.
go back to reference Vik T, Jacobsen G, Vatten L, Bakketeig LS (1996) Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev 45:245–255CrossRefPubMed Vik T, Jacobsen G, Vatten L, Bakketeig LS (1996) Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev 45:245–255CrossRefPubMed
7.
go back to reference von Kries R, Toschke AM, Koletzko B, Slikker W Jr (2002) Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol 156:954–961CrossRefPubMed von Kries R, Toschke AM, Koletzko B, Slikker W Jr (2002) Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol 156:954–961CrossRefPubMed
8.
go back to reference Wideroe M, Vik T, Jacobsen G, Bakketeig LS (2003) Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol 17:171–179CrossRefPubMed Wideroe M, Vik T, Jacobsen G, Bakketeig LS (2003) Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol 17:171–179CrossRefPubMed
9.
go back to reference Okuyemi KS, Ahluwalia JS, Harris KJ (2000) Pharmacotherapy of smoking cessation. Arch Fam Med 9:270–281CrossRefPubMed Okuyemi KS, Ahluwalia JS, Harris KJ (2000) Pharmacotherapy of smoking cessation. Arch Fam Med 9:270–281CrossRefPubMed
11.
go back to reference Peters MJ, Morgan LC (2002) The pharmacotherapy of smoking cessation. Med J Aust 176:486–490PubMed Peters MJ, Morgan LC (2002) The pharmacotherapy of smoking cessation. Med J Aust 176:486–490PubMed
12.
go back to reference Oncken CA, Kranzler HR (2003) Pharmacoptherapies to enhance smoking cessation during pregnancy. Drug Alcohol Rev 22:191–202CrossRefPubMed Oncken CA, Kranzler HR (2003) Pharmacoptherapies to enhance smoking cessation during pregnancy. Drug Alcohol Rev 22:191–202CrossRefPubMed
13.
go back to reference Newman MB, Shytle RD, Sanberg PR (1999) Locomotor behavioural effects of prenatal and postnatal nicotine exposure in rat offspring. Behav Pharmacol 10:699–706PubMedCrossRef Newman MB, Shytle RD, Sanberg PR (1999) Locomotor behavioural effects of prenatal and postnatal nicotine exposure in rat offspring. Behav Pharmacol 10:699–706PubMedCrossRef
14.
go back to reference Williams CM, Kanagasabai T (1984) Maternal adipose tissue response to nicotine administration in the pregnant rat: effects on fetal body fat and cellularity. Br J Nutr 51:7–13CrossRefPubMed Williams CM, Kanagasabai T (1984) Maternal adipose tissue response to nicotine administration in the pregnant rat: effects on fetal body fat and cellularity. Br J Nutr 51:7–13CrossRefPubMed
15.
go back to reference Ravussin E, Smith SR (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363–378PubMedCrossRef Ravussin E, Smith SR (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363–378PubMedCrossRef
16.
go back to reference Gao YJ, Holloway AC, Zeng ZH et al (2005) Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obesity Res 13:687–692 Gao YJ, Holloway AC, Zeng ZH et al (2005) Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obesity Res 13:687–692
17.
go back to reference Micu AL, Miksys S, Sellers EM, Koop DR, Tyndale RF (2003) Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism. J Pharmacol Exp Ther 306:941–947CrossRefPubMed Micu AL, Miksys S, Sellers EM, Koop DR, Tyndale RF (2003) Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism. J Pharmacol Exp Ther 306:941–947CrossRefPubMed
18.
go back to reference de Weerd S, Thomas CM, Kuster JE, Cikot RJ, Steegers EA (2002) Variation of serum and urine cotinine in passive and active smokers and applicability in preconceptional smoking cessation counselling. Environ Res 90:119–124CrossRefPubMed de Weerd S, Thomas CM, Kuster JE, Cikot RJ, Steegers EA (2002) Variation of serum and urine cotinine in passive and active smokers and applicability in preconceptional smoking cessation counselling. Environ Res 90:119–124CrossRefPubMed
19.
go back to reference Holness MJ, Langdown ML, Sugden MC (2000) Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of type 2 diabetes mellitus. Biochem J 349:657–665PubMed Holness MJ, Langdown ML, Sugden MC (2000) Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of type 2 diabetes mellitus. Biochem J 349:657–665PubMed
20.
go back to reference Petrik J, Reusens B, Arany E et al (1999) A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. Endocrinology 140:4861–4873CrossRefPubMed Petrik J, Reusens B, Arany E et al (1999) A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. Endocrinology 140:4861–4873CrossRefPubMed
21.
go back to reference Shen CN, Seckl JR, Slack JM, Tosh D (2003) Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 375:41–50CrossRefPubMed Shen CN, Seckl JR, Slack JM, Tosh D (2003) Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 375:41–50CrossRefPubMed
22.
go back to reference Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to development of type 2 diabetes in the rat. Diabetes 50:2279–2286PubMedCrossRef Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to development of type 2 diabetes in the rat. Diabetes 50:2279–2286PubMedCrossRef
23.
go back to reference Husain K, Scott BR, Reddy SK, Somani SM (2001) Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol 25:89–97CrossRefPubMed Husain K, Scott BR, Reddy SK, Somani SM (2001) Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol 25:89–97CrossRefPubMed
24.
go back to reference Yildiz D (2004) Nicotine, its metabolism and an overview of its biological effects. Toxicon 43:619–632CrossRefPubMed Yildiz D (2004) Nicotine, its metabolism and an overview of its biological effects. Toxicon 43:619–632CrossRefPubMed
25.
go back to reference Wetscher GJ, Bagchi M, Bagchi D et al (1995) Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 18:877–882CrossRefPubMed Wetscher GJ, Bagchi M, Bagchi D et al (1995) Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 18:877–882CrossRefPubMed
26.
go back to reference Kajimoto Y, Kaneto H (2004) Role of oxidative stress in pancreatic β-cell dysfunction. Ann NY Acad Sci 1011:168–176CrossRefPubMed Kajimoto Y, Kaneto H (2004) Role of oxidative stress in pancreatic β-cell dysfunction. Ann NY Acad Sci 1011:168–176CrossRefPubMed
27.
go back to reference Yoshikawa H, Hellstrom-Lindahl E, Grill V (2005) Evidence for functional nicotinic receptors on pancreatic β cells. Metabolism 54:247–254CrossRefPubMed Yoshikawa H, Hellstrom-Lindahl E, Grill V (2005) Evidence for functional nicotinic receptors on pancreatic β cells. Metabolism 54:247–254CrossRefPubMed
Metadata
Title
Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes
Authors
A. C. Holloway
G. E. Lim
J. J. Petrik
W. G. Foster
K. M. Morrison
H. C. Gerstein
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-0022-5

Other articles of this Issue 12/2005

Diabetologia 12/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.